Lactose (India) Experiences Revision in Its Stock Evaluation Amid Strong Market Performance

Dec 02 2024 09:20 AM IST
share
Share Via
Lactose (India) has garnered attention as its stock price reached an all-time high, reflecting a notable performance in the pharmaceutical sector. Recent adjustments in its evaluation indicate a positive trend, with the stock being added to MarketsMojo's list, highlighting its strong market position and impressive growth metrics. Lactose (India) has been on a remarkable upward trajectory, outperforming its sector and achieving significant returns over the past week. The stock opened with gains and maintained stability throughout the day, showcasing its resilience. With a year-over-year growth exceeding the broader market, Lactose (India) continues to demonstrate its potential in the competitive pharmaceutical landscape.
Lactose (India), a microcap pharmaceutical company, is currently in the spotlight as it recently achieved an all-time high stock price of Rs.218.85 on December 2nd, 2024. This remarkable milestone has drawn considerable attention from both investors and market analysts, reflecting the company's robust performance in a competitive sector.

According to MarketsMOJO, Lactose (India) has experienced a revision in its score, indicating a shift in evaluation that aligns with its recent upward trajectory. The stock has been on a notable upward trend for the past six days, showcasing a significant increase in returns that has outpaced the broader pharmaceutical and drugs sector by a noteworthy margin.

On the trading front, Lactose (India) opened with a gain of 2.51%, maintaining its position at the intraday high of Rs.218.85 throughout the day. This consistent performance underscores the stock's stability and resilience in the market.

In terms of technical indicators, Lactose (India) is currently trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This trend suggests a favorable outlook for the stock and reinforces its strong market position.

Over the past year, Lactose (India) has demonstrated impressive growth, achieving a remarkable 107.14% increase, significantly outpacing the Sensex's performance of 17.74%. This exceptional growth trajectory highlights the company's potential and success within the pharmaceutical industry.

In addition to its impressive performance metrics, Lactose (India) has also been added to MarketsMOJO's list, further solidifying its status as a noteworthy player in the market. With its strong fundamentals and positive growth indicators, Lactose (India) continues to be a company to watch closely in the evolving landscape of the pharmaceutical sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News